← Back to Search

Low-level Laser Therapy

Erchonia HLS for Tinnitus

N/A
Waitlist Available
Research Sponsored by Erchonia Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 8 week
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if a special red light can help reduce the ringing in the ears for adults with tinnitus. The light might work by calming nerves or reducing inflammation.

Eligible Conditions
  • Tinnitus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 8 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 8 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Total Score on the Tinnitus Handicap Inventory (THI).

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Erchonia HLSExperimental Treatment1 Intervention
635 nanometers (nm) laser application

Find a Location

Who is running the clinical trial?

Erchonia CorporationLead Sponsor
44 Previous Clinical Trials
2,064 Total Patients Enrolled
2 Trials studying Tinnitus
41 Patients Enrolled for Tinnitus
~1 spots leftby Nov 2025